Fig. 4
From: The Great Debate at “Melanoma Bridge”, Naples, December 7th, 2019
When is the best time to change treatment on anti-PD1 therapy: at disease progression or during stable disease? Audience response before and after debate
Fig. 4 | Journal of Translational Medicine